- Home
- ORMP
ORMP
Oramed Pharmaceuticals Inc.
as 05-09-2025 2:40pm EST
Upcoming Earnings Alert:
Get ready for potential market movements as Oramed Pharmaceuticals Inc. ORMP prepares to release earnings report on 12 May 2025.
| Founded: | 2002 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 48.3K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.48 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.82 - $3.09 | Next Earning Date: | 05-12-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Oramed Pharmaceuticals Inc. News
ORMP Breaking Stock News: Dive into ORMP Ticker-Specific Updates for Smart Investing
MT Newswires
11 days ago
Oramed Completes $36.9 Million Strategic Investment in Alpha Tau Medical
GlobeNewswire
11 days ago
Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals
PR Newswire
11 days ago
Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical
Zacks Small Cap Research
a month ago
ORMP: Upcoming Expected Milestones Include OraTech Spin-Off & IPO, Launch of Phase 3 Trial
Simply Wall St.
2 months ago
Oramed Pharmaceuticals And 2 Other Penny Stocks With Promising Potential
PR Newswire
2 months ago
Oramed Pharmaceuticals Issues Letter to Shareholders
Simply Wall St.
3 months ago
Oramed Pharmaceuticals And 2 Other US Penny Stocks To Watch
MT Newswires
3 months ago
Oramed Pharmaceuticals Forms Joint Venture to Commercialize Oral Insulin; Shares Rise
Compare ORMP vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ORMP Oramed Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.